Marianne De Backer Vir Biotechnology, Inc. (VIR) insider trading activity

Marianne De Backer is Chief Executive Officer of Vir Biotechnology, Inc.. Currently has a direct ownership of 769,505 shares of VIR, which is worth approximately $5.16 Million. The most recent transaction as insider was on Apr 03, 2025, when has been sold 79,712 shares (Common Stock) at a price of $5.95 per share, resulting in proceeds of $474,286. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 770K

23.05% 3M change

13.42% 12M change

Total Value Held $5.16 Million

Marianne De Backer Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Apr 03 2025	SELL Open market or private sale	$474,286 $5.95 p/Share	79,712 Reduced 9.39%	769,505 Common Stock
Feb 24 2025	SELL Open market or private sale	$152,352 $9.45 p/Share	16,122 Reduced 1.86%	849,217 Common Stock
Feb 22 2025	BUY Grant, award, or other acquisition	-	240,000 Added 21.71%	865,339 Common Stock
Jun 12 2024	SELL Other acquisition or disposition	-	53,118 Reduced 7.83%	625,339 Common Stock
Apr 03 2024	SELL Open market or private sale	$690,532 $9.46 p/Share	72,995 Reduced 9.71%	678,457 Common Stock
Feb 22 2024	BUY Grant, award, or other acquisition	-	175,000 Added 18.89%	751,452 Common Stock
Apr 03 2023	BUY Grant, award, or other acquisition	-	576,452 Added 50.0%	576,452 Common Stock

Also insider at

ARWR

ARROWHEAD PHARMACEUTICALS, INC. Healthcare

Director

KRON

Kronos Bio, Inc. Healthcare

Director

MDB